Joining us today is Jamie Tadelis, Chief Product & Investor Officer at SC Lowy. Jamie is one of the co-founders of SC Lowy and is currently based in their New York office, where he serves as the firm's Chief Product and Investor Officer focusing on existing and new investment vehicles, investor relationships, and ESG initiatives. Throughout his tenure at SC Lowy, Jamie has held various key roles, including Head of Sales, General Counsel, and Chief Compliance Officer, all while based in Hong Kong.

Before joining SC Lowy, Jamie served as General Counsel, Chief Compliance Officer, and a member of the Investment Committee at Abax Global Capital, a Hong Kong-based special situations asset manager. Prior to Abax, he was part of Avenue Capital Group's Asia-focused investment team in New York and Hong Kong, where he provided legal structuring expertise and guided investments through various bankruptcy and restructuring regimes across APAC.

Jamie's career began at JPMorgan in emerging markets structured products, followed by his role as a restructuring attorney at Kramer Levin (now Herbert Smith Freehills Kramer) in New York.

He holds a BA with a concentration in Management Information Systems from the State University of New York at Albany, a J.D. from Fordham University School of Law, Series 7, 63 and 24 licenses with FINRA and RO and Type 1 registrations with the Hong Kong SFC.

Our guests today are Chung Ma, Deputy Chief Investment Officer of the Virginia Retirement System, and Vivian Lau, CEO and CIO of Senado Management. Beyond their remarkable careers, Chung and Vivian share a unique personal connection—they are cousins who grew up together in the same household in Flushing, New York.

Chung helps oversee the investment portfolio of the Virginia Retirement System, one of the largest public pension funds in the United States, managing more than $100 billion on behalf of public employees and retirees. His expertise spans asset allocation, portfolio construction, risk management, trading systems, and long-term institutional investing.

Vivian is the founder of Senado Management, a special situations investment firm focused on opportunistic investments across credit, equities, and private markets. Most recently, she led Strategic Themes investing at Sixth Street and previously served as Co-Chief Investment Officer of Serengeti Asset Management after beginning her career in Goldman Sachs' renowned Special Situations Group, where she became a Managing Director at just 28 years old.

Today we'll explore their career journeys, how they each developed their investment philosophies, and how two cousins from the same family built exceptional careers across public and private investing.

Without further ado, here is our conversation with Chung and Vivian.

Our guest for today's podcast is Dr. Gaurav Aggarwal. Dr. Aggarwal is a Managing Partner at Vivo Capital, a global healthcare specialist with a multi-strategy investment platform covering venture capital, private equity, and public equity strategies. The firm seeks to support the expansion of healthcare access via investments in the industry, and to catalyze innovation and growth via its "Ecosystem Strategy."

Dr. Aggarwal and has invested in the life sciences sector for over 25 years including almost 10 years at Vivo Capital at the time of this recording. Prior to Vivo, Dr. Aggarwal was Chief Business Officer of Ocera Therapeutics, a publicly traded clinical-stage company, prior to which he served as a General Partner at Panorama Capital. He began his career in private equity at JPMorgan Partners. Dr. Aggarwal currently serves on the board of Unicycive Therapeutics and on the boards of several private companies across the medical device, pharmaceutical services and biopharmaceutical sectors.

Dr. Aggarwal received his M.D. from Columbia University, College of Physicians & Surgeons and his B.S. in Agricultural Economics from Cornell University.

Without further ado, here is our conversation with Gaurav Aggarwal.